Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 2
2014 1
2017 1
2018 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
Burade V, Bhowmick S, Maiti K, Zalawadia R, Ruan H, Thennati R. Burade V, et al. Among authors: thennati r. BMC Cancer. 2017 Jun 6;17(1):405. doi: 10.1186/s12885-017-3377-3. BMC Cancer. 2017. PMID: 28587612 Free PMC article.